Jones Trading Upgrades Adaptimmune Therapeutics plc (ADAP) to Buy on improving biotech sector

March 7, 2024 12:24 PM EST Send to a Friend
(Updated - March 7, 2024 12:25 PM EST)

Jones Trading analyst Soumit Roy upgraded Adaptimmune Therapeutics plc (NASDAQ: ADAP) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login